AscellaHealth Identifies Key Trends Worth Watching in 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024. As industry stakeholders brace for transformative changes across the healthcare ecosystem, AscellaHealth is at the forefront of patient-centric care with optimized outcomes and is positioned to support key stakeholders including patients, life sciences and biotechnology manufacturers, payers and providers with innovative solutions such as pre-commercialization and market access, product launches, exclusive distribution, international fulfillment and beyond for specialty drugs, cell and gene therapies (CGTs) designed to treat rare diseases and complex conditions.

Dea Belazi, president and CEO, AscellaHealth, emphasizes the company's commitment to putting patients first, saying, "Our unwavering dedication to patients remains paramount and is woven into all the developments we see unfolding in 2024. In reviewing these trends, it becomes evident that the economic and regulatory environment will impact every stakeholder.”

To read more, click here.